Menu Back toS35-The-Appropriate-Use-of-Drugs-in-Asia-Countries-Especially-Elder-Patients
16th DIA Japan Annual Meeting 2019
[S35] The Appropriate Use of Drugs in Asia Countries, Especially Elder Patients
Junko Sato, PhD
- Director, Office of International Programs
- Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Although Japan is famous for centenarian population, the aging of population is a common problem in Asia. Weight fluctuations and organ dysfunction associated with aging are wellknown facts. However, only few of the drug package inserts include information about the elderly. We will share the current status of the appropriate use of drugs for the elderly and cautionary statements included in package inserts in the aging Asian countries and consider more appropriate pharmacotherapy for the elderly by cooperating with other Asian countries that are experiencing the same situation.
'The Appropriate Use of Drugs in Elder Patients: A Malaysian Perspective'
Azri Bin Nasruddin, MSc, RPh
- Senior Principal Assistant Director, New Drug Section
- National Pharmaceutical Regulatory Agency (NPRA),Centre for Product Registration, Malaysia
Outlook of the Current Labeling in Asia and the Future for Elderly Patients
Rie Matsui, RPh
- Senior Director, Regional Labeling Head for APAC
- Pfizer R&D, Japan